Psychemedics Other Long-Term Assets 2010-2024 | PMD
Psychemedics other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Psychemedics Annual Other Long-Term Assets (Millions of US $) |
2023 |
$1 |
2022 |
$1 |
2021 |
$1 |
2020 |
$1 |
2019 |
$1 |
2018 |
$1 |
2017 |
$1 |
2016 |
$1 |
2015 |
$1 |
2014 |
$1 |
2013 |
$1 |
2012 |
$0 |
2011 |
$0 |
2010 |
$0 |
2009 |
$0 |
Psychemedics Quarterly Other Long-Term Assets (Millions of US $) |
2024-09-30 |
$1 |
2024-06-30 |
$1 |
2024-03-31 |
$1 |
2023-12-31 |
$1 |
2023-09-30 |
$1 |
2023-06-30 |
$1 |
2023-03-31 |
$1 |
2022-12-31 |
$1 |
2022-09-30 |
$1 |
2022-06-30 |
$1 |
2022-03-31 |
$1 |
2021-12-31 |
$1 |
2021-09-30 |
$1 |
2021-06-30 |
$1 |
2021-03-31 |
$1 |
2020-12-31 |
$1 |
2020-09-30 |
$1 |
2020-06-30 |
$1 |
2020-03-31 |
$1 |
2019-12-31 |
$1 |
2019-09-30 |
$1 |
2019-06-30 |
$1 |
2019-03-31 |
$1 |
2018-12-31 |
$1 |
2018-09-30 |
$1 |
2018-06-30 |
$1 |
2018-03-31 |
$1 |
2017-12-31 |
$1 |
2017-09-30 |
$1 |
2017-06-30 |
$1 |
2017-03-31 |
$1 |
2016-12-31 |
$1 |
2016-09-30 |
$1 |
2016-06-30 |
$1 |
2016-03-31 |
$1 |
2015-12-31 |
$1 |
2015-09-30 |
$1 |
2015-06-30 |
$1 |
2015-03-31 |
$1 |
2014-12-31 |
$1 |
2014-09-30 |
$1 |
2014-06-30 |
$1 |
2014-03-31 |
$1 |
2013-12-31 |
$1 |
2013-09-30 |
$1 |
2013-06-30 |
$0 |
2013-03-31 |
$0 |
2012-12-31 |
$0 |
2012-09-30 |
$0 |
2012-06-30 |
$0 |
2012-03-31 |
$0 |
2011-12-31 |
$0 |
2011-09-30 |
$0 |
2011-06-30 |
$0 |
2011-03-31 |
$0 |
2010-12-31 |
$0 |
2010-09-30 |
$0 |
2010-06-30 |
$0 |
2010-03-31 |
$0 |
2009-12-31 |
$0 |
2009-09-30 |
$0 |
2009-06-30 |
$0 |
2009-03-31 |
$0 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Outpatient & Home Care |
$0.014B |
$0.022B |
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
|